In Depth 9 Apr 2025 Cystic fibrosis: is the next blockbuster a gene therapy? Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need. April 9, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Apr 2025 Top biotech deals of March 2025 Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations. April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 31 Mar 2025 AstraZeneca bets on Asia: a surge of deals in March amid fraud probe AstraZeneca has vowed to spend over $10 billion in Asia, particularly in China, to build Beijing into an R&D hub amid probe into fraud scandals. March 31, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Mar 2025 These 7 biotechs are shaping the next generation of endometriosis care As we observe Endometriosis Awareness Month in March, let us take a look at seven biotechs advancing promising candidates in the clinic. March 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2025 First-ever RIPTAC enters clinic: all you need to know about this new cancer approach The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics. March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2025 Depression drug trials are failing—and placebos are to blame In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research. March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field. March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Mar 2025 Nine biotechs thriving in Seattle in 2025 In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large. March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Mar 2025 Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field. March 12, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2025 23andMe: the collapse of a genomics giant 23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold? March 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Mar 2025 Top biotech deals of February 2025 Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations. March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Feb 2025 Rare Disease Day: seven drugs awaiting approval in 2025 As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in 2025. February 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email